Roka Bioscience, Inc. (NASDAQ:ROKA) Files An 8-K Results of Operations and Financial Condition

Roka Bioscience, Inc. (NASDAQ:ROKA) Files An 8-K Results of Operations and Financial Condition

Story continues below

Item 2.02. Results of Operations and Financial Condition.

On May 11, 2017, Roka Bioscience, Inc. (the “Company”) issued a
press release announcing its financial results for the three
months ended March 31, 2017. A copy of the press release is being
furnished as Exhibit 99.1 to this Report on Form 8-K.
The information in this Report on Form 8-K and Exhibit 99.1
attached hereto is intended to be furnished and shall not be
deemed filed for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the Exchange Act) or otherwise
subject to the liabilities of that section, nor shall it be
deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except
as expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No.
Description
99.1
Press release issued by Roka Bioscience, Inc. dated May
11, 2017, furnished hereto.


About Roka Bioscience, Inc. (NASDAQ:ROKA)

Roka Bioscience, Inc. is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company’s Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.

Roka Bioscience, Inc. (NASDAQ:ROKA) Recent Trading Information

Roka Bioscience, Inc. (NASDAQ:ROKA) closed its last trading session down -0.14 at 3.41 with 30,141 shares trading hands.

An ad to help with our costs